Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | DAO | P14920 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL851363 | 1.00 | ALDH1A1 (0.55) | ALDH1A1GAATSHRLPAR3LPAR1 | |
| SCHEMBL345679 | 1.00 | ALDH1A1 (0.55) | ALDH1A1GAATSHRLPAR3LPAR1 | |
| SCHEMBL2516058 | 1.00 | ALDH1A1 (0.55) | ALDH1A1GAATSHRLPAR3LPAR1 | |
| SCHEMBL310641 | 1.00 | — | — | |
| SCHEMBL2513750 | 1.00 | ALDH1A1 (0.55) | ALDH1A1GAATSHRLPAR3LPAR1 | |
| SCHEMBL2511604 | 1.00 | ALDH1A1 (0.55) | ALDH1A1GAATSHRLPAR3LPAR1 | |
| SCHEMBL17167087 | 1.00 | ALDH1A1 (0.55) | ALDH1A1GAATSHRLPAR3LPAR1 | |
| Hydrochloric Acid SCHEMBL9577938 | 0.96 | ALDH1A1 (0.52) | ALDH1A1GAATSHRLPAR3LPAR1 | |
| SCHEMBL409239 | 0.95 | — | — | |
| SCHEMBL20314605 | 0.89 | ALDH1A1 (0.48) | ALDH1A1GAATSHRUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8034735-B2 | Catalyst component for the polymerization of olefins | Basell Poliolefine Italia, s.r.l. (IT) | 2011-10-11 | — | — | US | claimed |
| US-20100120998-A1 | CATALYST COMPONENT FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE ITALIA S.R.L. (IT) | 2010-05-13 | — | — | US | claimed |
| CN-101589068-A | Catalyst component for olefin polymerization | BASELL POLIOLEFINE SRL (IT) | 2009-11-25 | — | — | CN | claimed |
| CN-113574041-B | Bisphenol production method and polycarbonate resin production method | 三菱化学株式会社 | 2023-10-13 | — | — | CN | disclosed |
| CN-113574041-A | Method for producing bisphenol and method for producing polycarbonate resin | 三菱化学株式会社 | 2021-10-29 | — | — | CN | disclosed |
| EP-2735581-B1 | COMPOSITION AND POLYMER | ASAHI CHEMICAL IND (JP) | 2021-07-14 | — | — | EP | disclosed |
| WO-2020189201-A1 | METHOD FOR PRODUCING BISPHENOL AND METHOD FOR PRODUCING POLYCARBONATE RESIN | 三菱ケミカル株式会社 | 2020-09-24 | — | — | WO | disclosed |
| US-9738757-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-9676802-B2 | Hepatitis C virus inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2017-06-13 | — | — | US | disclosed |
| CN-103282363-B | Imidazoquinoline derivative and pharmaceutically acceptable salt thereof, preparation method and medical application thereof | 上海恒瑞医药有限公司 | 2016-08-10 | — | — | CN | disclosed |
| US-20160222168-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-08-04 | — | — | US | disclosed |
| CN-103282363-A | Imidazoquinoline derivative and pharmaceutically acceptable salt thereof, preparation method and medical application thereof | SHANGHAI HENGRUI PHARM CO LTD | 2013-09-04 | — | — | CN | disclosed |
| US-8217153-B2 | an eluant containing an organic-solvent is used at a first pH to remove non-target solutes and suspended entities from an affinity chromatography column, the pH of the eluant is then changed to a second pH, and the organic-solvent-containing eluant is used to elute target molecules from the column | AMGEN INC. (US) | 2012-07-10 | — | — | US | disclosed |
| US-20120123168-A1 | PRODUCTION OF FUEL FROM CHEMICALS DERIVED FROM BIOMASS | ENLIGHTEN INNOVATIONS INC. (CA) | 2012-05-17 | — | — | US | disclosed |
| US-8034735-B2 | Catalyst component for the polymerization of olefins | Basell Poliolefine Italia, s.r.l. (IT) | 2011-10-11 | — | — | US | disclosed |
| US-20100130727-A1 | Methods and Systems for Isolating Target Molecules from Complex Solutions by Column-Chromatography Using Eluants Containing Organic Solvents | AMGEN INC. | 2010-05-27 | — | — | US | disclosed |
| US-7718343-B2 | Decomposable resin composition and pattern-forming material including the same | FUJIFILM CORPORATION (JP) | 2010-05-18 | — | — | US | disclosed |
| US-20100120998-A1 | CATALYST COMPONENT FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE ITALIA S.R.L. (IT) | 2010-05-13 | — | — | US | disclosed |
| CN-101589068-A | Catalyst component for olefin polymerization | BASELL POLIOLEFINE SRL (IT) | 2009-11-25 | — | — | CN | disclosed |
| US-20080070154-A1 | DECOMPOSABLE RESIN COMPOSITION AND PATTERN-FORMING MATERIAL INCLUDING THE SAME | FUJIFILM CORPORATION (JP) | 2008-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120123168-A1 | PRODUCTION OF FUEL FROM CHEMICALS DERIVED FROM BIOMASS | ME3, HOGA1, ALAD | ALDH1A1 210/4885GAA 205/4885TSHR 3918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.